NCT05492422 Central Executive Training and Parent Training for ADHD
| NCT ID | NCT05492422 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida State University |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-10-03 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-10-03 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities. BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors. Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.
Eligibility Criteria
Inclusion: 1. Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and 2. parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants). All DSM-5 ADHD presentations will be eligible. Exclusion: 1. gross neurological, sensory, or motor impairment; 2. history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use); 3. intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score \<70; 4. conditions requiring acute intervention, e.g., active suicidality; and 5. non-English speaking child or parent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05492422 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05492422 currently recruiting?
Yes, NCT05492422 is actively recruiting participants. Contact the research team at clc@psy.fsu.edu for enrollment information.
Where is the NCT05492422 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT05492422 clinical trial?
NCT05492422 is sponsored by Florida State University. The trial plans to enroll 200 participants.